ОСТЕОПОРОЗ В ПРАКТИКЕ ПУЛЬМОНОЛОГА
- Авторы: Баранова И.А1
-
Учреждения:
- РНИМУ им. Н.И. Пирогова Минздрава России
- Выпуск: № 2s (2013)
- Страницы: 14-21
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/280259
- ID: 280259
Цитировать
Полный текст
![Открытый доступ](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Аннотация
Обзор посвящен проблеме вторичного остеопороза (ОП) в практике врача-пульмонолога. Это заболевание может быть обусловлено приемом глюкокортикостероидов, прежде всего пероральных, а также развиваться вне зависимости от проводимой терапии как осложнение тяжелого течения заболевания. ОП как коморбидное заболевание рассматривается при хронической обструктивной болезни легких, бронхиальной астме, муковисцидозе, саркоидозе, интерстициальных легочных заболеваниях, у больных, нуждающихся в трансплантации легких. Представлены рекомендации по диагностике ОП, профилактике и лечению его глюкокортикоидной формы.
Полный текст
![Доступ закрыт](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Об авторах
И. А Баранова
РНИМУ им. Н.И. Пирогова Минздрава России
Email: baranova@ro.ru
Кафедра госпитальной терапии педиатрического факультета; д.м.н., проф. кафедры
Список литературы
- Kanis JA. Smoking and fracture risk: a metaanalysis Osteoporos Int 2005;16(2):155-62.
- Barnes PJ, Celli BR. Systemic manifestation and comorbidities of COPD. Eur Respir J 2009;33:1165-85.
- Kong YY. Molecular control of bone remodeling and osteoporosis. Exp Gerontol 2000;35(8):947-56.
- Sabit R, Bolton CE, Edwards PH, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175:1259-65.
- Bolton CE, Ionescu AA, Shiels KM, et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;170:1286-93.
- Graat-Verboom EFM, Wouters FWJM, Smeenk, et al. Current status of research on osteoporosis in COPD: a systematic review. J Respir J 2009;34:209-18.
- Nuti R. Vertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO Study. Osteoporos Int 2009;20(6):989-98.
- Kjensli A, Falch JA, Ryg M, et al. High prevalence of vertebral deformities in COPD patients: relationship to disease severity. Eur Respir J 2009;33:1018-24.
- Dam TT. Bone mineral density and fractures in older men with chronic obstructive pulmonary disease or asthma. Osteoporos Int 2010;21(8):1341-49.
- Cystic Fibrosis Foundation, Patient Registry 2010.
- Annual Report, Cystic Fibrosis Foundation, Bethesda, Md, USA, 2012.
- Shead EF, Haworth CS, Gunn E, et al. Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis. Am J Respir Crit Care Med 2006;174:306-11.
- Shead EF, Haworth CS, Barker H, et al. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J Cyst Fibros 2010;9:93-8.
- King SL, Topliss DJ, Kotsimbos T, et al. Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor. Eur Respir J 2005;25:54-61.
- Aris RM, Guise TA. Cystic fibrosis and bone disease: are we missing a genetic link? Eur Respir J 2005;25(1):9-11.
- Shead EF, Haworth CS, Condliffe AM, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone. Thorax 2007;62:650-51.
- Le Heron L, Guillaume C, Velard F, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) regulates the production of osteoprotegerin (OPG) and prostaglandin (PG) E2 in human bone. J Cyst Fibros 2010;9:69-72.
- Aris RM, Renner JB, Winders AD, et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann Int Med 1998;128(3):186-93.
- Aringer M, Kiener HP, Koeller MD, et al. High turnover bone disease following lung transplantation. Bone 1998;23(5):485-88.
- Buntain HM, Greer RM, Schluter PJ, et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 2004;59:149-55.
- Красовский С.А., Баранова И.А., Амелина Е.Л. и др. Минеральная плотность костной ткани, частота деформаций позвонков и периферических переломов у взрослых больных муковисцидозом // Пульмонология 2011. № 5. С. 71-8.
- Paccou J, Zeboulon N, Combescure C, et al. The prevalence of osteoporosis, osteopenia, and fractures: a systematic literature review with meta-analysis. Calcif Tissue Int 2010;86:1-7.
- Elkin SL, Fairney A, Burnett S, et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis: a cross-sectional study. Osteoporos Int 2001;12:366-72.
- Stephenson A, Jamal S, Dowdell T, et al. Prevalence of vertebral fractures in adults with cystic fibrosis and their relationship to bone mineral density. Chest 2006;130:539-44.
- Aris RM, Merkel PA, Bachrach LK, et al. Consensus statement: Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005;90(3):1888-96.
- Report of the UK Cystic Fibrosis Trust Bone Mineralisation Working Group. Bone mineralisation in cystic fibrosis. Cystic Fibrosis Trust. 2007.
- Саркоидоз / Под ред. А.А.Визеля. Серия монографий Российского респираторного общества. Гл. ред. серии А.Г. Чучалин М., 2010. 416 с.
- Burke RR, Rybicki BA, Rao DS. Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin Respir Crit Care Med 2010;31:474-84.
- Conron M. Calcium metabolism in sarcoidosis and its clinical implications. Rheumatology (Oxford) 2000;39(7):707-13.
- Sweiss NJ, Lower EE, Korsten P, et al. Bone health issues in sarcoidosis. Curr Rheumatol Rep 2011;13:265-72.
- Pauwels RA, Lofdahl C-G, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999;340(25):1948-53.
- Ferguson GT, Calverley PMA, Anderson JA, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009;136(6):1456-65.
- Jones A, Fay JK, Burr M, et al. Inhaled corticosteroid effects on bone metabolism in asthma and mild obstructive pulmonary disease. Cochrane Library 2002;3:CD003537.
- Weatherall M. Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids. Clin Exp Allergy 2008;38(9): 1451-58.
- Остеопороз/ Под ред. О.М. Лесняк, Л.И. Беневоленской. 2-е изд. М., 2009. 272 с
- http://www.ginasthma.org/uploads/users/ files/GINA_Russian_2011.pdf
- van Staa TP, Leufkens HG, Abenhaim L, et al. Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 2000;39:1383-89.
- Van Staa TP, Leufkens HG, Abenhaim L, et al. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000,15: 933-1000.
- Лесняк О.М., Баранова И.А., Торопцова Н.В. Клинические рекомендации «Диагностика, профилактика и лечение глюкокортикоидного остеопороза у мужчин и женщин 18 лет и старше». Ярославль, 2013.
- International Guidelines for the selection of lung transplant candidates. 1998.
- International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update - A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. 2006.
- Ebeling PR. Approach to the patient with transplantation-related bone loss J Clin Endocrinol Metab 2009;94:1483-90.
- Ebeling PR. Transplantation osteoporosis In: Rosen CJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism. 7th ed. Chap. 61. Washington, DC: American Society for Bone Mineral Research; 2008:279-85.
- Shane E, Papadopoulos A, Staron RB et al. Bone loss and fracture after lung transplantation 1999;68:220-27.
- Kanis JA, Johansson H, Oden A, et al. A metaanalysis of prior corticosteroid use and fracture risk. J Bone Miner Res 2004;19:893-99.
- Kanis JA, Johansson H, Oden A, et al. Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 2011;22:809-16.
- Клинические рекомендации по профилактике и ведению больных с остеопорозом / Под ред О.М. Лесняк. Ярославль, 2012. 24 с.
Дополнительные файлы
![](/img/style/loading.gif)